COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

January 19, 2021

Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient

Journal of Medical Virology
Maria Chiara UgolottiFrancesco Facchinetti
January 20, 2021

ACEi reduces hypertension-induced hyperinflammation in COVID-19

Nature Reviews. Cardiology
Gregory B Lim
January 20, 2021
Open Access

State-of-the-Art Risk Models for Diabetes, Hypertension, Visual Diminution, and COVID-19 Severity in Mexico

MedRxiv : the Preprint Server for Health Sciences
H. AmayaAlejandro Noriega
January 20, 2021
Open Access

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma

MedRxiv : the Preprint Server for Health Sciences
T. MaNigel Paneth
January 19, 2021

Ensuring contact: calling rural Appalachian older adults during the COVID-19 epidemic

Rural and Remote Health
Robert B WalkerAdam D Baus
January 19, 2021

Pulmonary Hypertension in COVID-19 Pneumoniae: It Is Not Always as It Seems

European Journal of Case Reports in Internal Medicine
Maria Cristina PasqualettoFausto Rigo
January 20, 2021

Impact of COVID-19 on in vivo work and patient sample availability for cancer research

Nature Reviews. Cancer
Eoghan J Mulholland
January 20, 2021
Open Access

Modelling the Long-Term Effects of Covid-19 Cancer Services Disruption on Patient Outcome in Scotland

MedRxiv : the Preprint Server for Health Sciences
Jonine FigueroaD. Weller
January 19, 2021
Open Access

The assessment of high sensitivity cardiac troponin in patients with COVID-19: a multicenter study

IJC Heart & Vasculature
Marco Alfonso PerroneSergio Bernardini
January 19, 2021
Open Access

Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients

Archivos argentinos de pediatría
Pedro TaffarelClaudia Meregallia
January 19, 2021

Prevalence of Alcohol and Tobacco Use in India and Implications for COVID-19 - Niyantrita Madhumeha Bharata Study Projections

Journal of Medicine and Life
Madhava Sai SivapuramHongasandra Ramarao Nagendra
January 20, 2021
Open Access

Higher comorbidities and early death in hospitalized African-American patients with Covid-19

BMC Infectious Diseases
Raavi GuptaM A Haseeb

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2021 Meta ULC. All rights reserved